Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


House Commerce FDA reform bill markup expected by mid-July.

This article was originally published in The Rose Sheet

Executive Summary

HOUSE COMMERCE FDA REFORM BILL MARKUP EXPECTED BY MID-JULY with the goal of having legislation through the House in time for conference before Congress' summer recess, set to begin Aug. 2. The Senate FDA Reform/Prescription Drug User Fee Act reauthorization bill (S 830) was reported out of the Senate Labor Committee June 18 ("The Rose Sheet" June 23, p. 12).



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts